229 COVID-19 Vaccines Q&A: The Two-Dose Strategy, Speeding up Rollouts, and Very Normal Side Effects
Public Health On Call
The Johns Hopkins Bloomberg School of Public Health
4.6 • 644 Ratings
🗓️ 8 January 2021
⏱️ 15 minutes
🧾️ Download transcript
Summary
With a shortage of COVID-19 vaccines, is it a good idea to give people just one dose now and a second dose later when there is more available? How can the process of rolling out vaccines be sped up? What do we know about potential side effects? Which vaccine should I get? Immunologist Dr. Gigi Gronvall from the Center for Health Security talks with Stephanie Desmon to answer these questions and more about COVID-19 vaccines.
KEYWORDS: vaccine hesitancy; herd immunity
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Season 3, a Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health. |
| 0:12.3 | I'm Josh Sharfstein, Vice Dean for Public Health Practice and Community Engagement, and a former secretary of Maryland's Health Department. |
| 0:19.6 | Our goal is to bring scientific evidence |
| 0:22.4 | and experience to the public health news of the day through informative interviews with scientists, |
| 0:27.8 | community leaders, policy experts, public health officials, clinicians, and more. If you have ideas |
| 0:34.4 | or questions for us to cover, please email us at public health question |
| 0:38.8 | at jhhhu.edu. That's public health question at jhhu.edu for future podcast episodes. |
| 0:47.3 | Today, Stephanie Desmond talks to Gigi Granval from the Johns Hopkins Center for Health |
| 0:51.9 | Security about the COVID-19 vaccine rollout. They discussed |
| 0:56.0 | distribution challenges, vaccine side effects, and why sticking to the recommended two-dose |
| 1:02.2 | regimen makes more scientific sense than giving more people a single dose of vaccine. Let's listen. |
| 1:09.1 | Gigi Granval, thanks so much for joining me. Thank you so much. It's great to be here. |
| 1:14.1 | So we're going to talk today about the COVID vaccines. And the thing on everyone's mind, I think, |
| 1:19.9 | right now is a conversation that's being had. The vaccines that we have available now are much |
| 1:24.9 | more effective after two doses, but there's a conversation |
| 1:28.2 | because of a shortage of vaccines that maybe we should give one dose and then a second |
| 1:33.7 | dose much later. So I'm curious if you could sort of explain that to us a little and then tell |
| 1:38.8 | us about, you know, what that means. Sure. So everything is really, you know, there's this ideal case where we have as much supply |
| 1:49.4 | as we need. We have a lot of people who are willing to take it and then we give them vaccine, |
| 1:55.2 | right? So unfortunately, not all of those variables are, you know, are fantastic. |
| 2:01.2 | So we have a great need to vaccinate people as quickly as possible because, you know, |
| 2:07.5 | we want to protect people from COVID, but also we're concerned about new variants popping |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Johns Hopkins Bloomberg School of Public Health, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Johns Hopkins Bloomberg School of Public Health and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.